Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Women's Health Rheumatology Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Clinical Trial ● Currently Recruiting NCT05719259

Perpetual Observational Study – Ventilator Associated Pneumonia

Perpetual Observational Study – Ventilator Associated Pneumonia — Recruiting • Respiratory / COPD / Asthma • NCT05719259.

📅 10 Sep 2026 ⏱ 2 min read
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient before referring.
Status
Currently Recruiting
NCT ID
NCT05719259
Sponsor
European Clinical Research Alliance for Infectious Diseases (ECRAID)
Start
2022-08-03
ClinicaliQ Trial Snapshot
  • Perpetual Observational Study – Ventilator Associated Pneumonia — Recruiting • Respiratory / COPD / Asthma • NCT05719259.
  • What is being tested: This perpetual observational study is monitoring the epidemiology, microbiology, and outcomes of ventilator-associated pneumonia (VAP) in ICU patients requiring mechanical ventilation, tracking bacterial resistance patterns and clinical management strategies.
  • Patient eligibility overview: The study includes adult ICU patients who develop bacterial respiratory infections while mechanically ventilated, with ongoing recruitment to capture contemporary VAP cases and their associated risk factors.
Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

Ventilator-Associated Pneumonia (VAP) is a bacterial respiratory infection that patients in the Intensive Care Unit (ICU) often get when they cannot breathe for themselves and require mechanical ventilation. It is linked to higher chances of death, a longer stay in the hospital, higher costs, and the use of more antibiotics. Options to help prevent or treat this disease are in development and will require evaluation in future clinical trials. The goal of POS-VAP is to build and continuously train a network of ICUs to be prepared for doing these trials,…

Eligibility Snapshot
  • : * Age≥18 years * At risk of acquiring VAP during ICU stay, defined as: * Requiring admission or being admitted to the ICU. * Expected or documented to be under IMV for more than 48 hours. * Consent, either a written informed consent given by the study patient in full medical, psychological, cognitive, social or legal capacity to give an informed consent, or, if not possible, by a Legally Authorized Representative of the study patient OR any applicable locally accepted form of consent OR consent waiver allowing data collection and sharing of data according to ECRAID's principles

Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Clinical Brief
Same-day test helps doctors detect hidden infections in critically ill children
Respiratory / COPD / Asthma · BBC Health · 16 Oct 2026
Metagenomic testing enables rapid, same-day identification of infectious pathogens in critically ill children, potentially improving diagnostic speed compared to conventional culture methods…
View brief →
Clinical Brief
Mum told to ‘prepare for worst’ urges others to get respiratory illness vaccine
Respiratory / COPD / Asthma · BBC Health · 13 Oct 2026
RSV vaccination in pregnancy is now available and recommended; Jo Goldsmith's case highlights the clinical value of preventing severe respiratory syncytial virus…
View brief →
Clinical Brief
RSV vaccination: expansion of eligibility to older adults in certain clinical risk groups
Respiratory / COPD / Asthma · NHS England · 01 Jul 2026
From September 2026, RSV vaccination eligibility expands beyond the current age-based criteria to include older adults in specific clinical risk groups, requiring…
View brief →
Clinical Brief
Latest UKHSA weekly winter virus surveillance data
Respiratory / COPD / Asthma · UKHSA · 08 Oct 2026
Winter Virus Surveillance Summary UKHSA continues systematic weekly monitoring of respiratory viruses throughout the 2026/27 winter season to track circulation patterns and…
View brief →
Clinical Brief
US mother begged for help before her children’s killings, mother-in-law testifies
Respiratory / COPD / Asthma · BBC Health · 18 Aug 2026
Postpartum psychosis represents a psychiatric emergency requiring urgent recognition and intervention, as illustrated by this case where a mother in acute distress…
View brief →
Guideline
XVIVO Perfusion System (ex-situ machine perfusion) for assessing and reconditioning marginal lungs for transplantation: early-use assessment
Respiratory / COPD / Asthma · 21 Oct 2026
XVIVO Perfusion System enables ex-situ assessment of marginal donor lungs before transplantation, allowing objective evaluation of organ viability and function to improve…
View guideline →